Dr. Khatiwada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5140 N California Ave
Chicago, IL 60625Phone+1 773-907-3038Fax+1 773-989-3815
Education & Training
- Washington University/B-JH/SLCH ConsortiumChief Residency, Internal Medicine, 2020 - 2021
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2017 - 2020
- Indiana University School of MedicineClass of 2017
Certifications & Licensure
- IL State Medical License 2020 - 2026
- MO State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 11 citationsEffectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases.Quazim A. Alayo, Aava Khatiwada, Anish Patel, Maria Zulfiqar, Anas Gremida
Inflammatory Bowel Diseases. 2021-10-18 - 18 citationsReal-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.Marc Fenster, Quazim A. Alayo, Aava Khatiwada, Wenfei Wang, Christina Dimopoulos
Clinical Gastroenterology and Hepatology. 2021-10-01 - 64 citationsSafety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis.Parakkal Deepak, Quazim A. Alayo, Aava Khatiwada, Bixuan Lin, Marc Fenster
Clinical Gastroenterology and Hepatology. 2021-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: